Biogen Discontinues Gosuranemab Trial in Progressive Supranuclear Palsy
Biogen on Twitter: "Chris Henderson, VP, Neuromuscular and Movement Disorders Research Unit, highlights the importance of an early Progressive Supranuclear Palsy (PSP) diagnosis #PSPAwareness https://t.co/xDnZaZYYhT" / Twitter
Biogen's Tau Antibody for Progressive Supranuclear Palsy Fails Trial | BioSpace
Overview of Tau immunotherapies in clinical trial. Indicated are... | Download Scientific Diagram
Biogen 2019 Outlook (NASDAQ:BIIB) | Seeking Alpha
Medscape - After disappointing trial results, Biogen will discontinue development of gosuranemab for PSP and other primary tauopathies. http://ms.spr.ly/6185Tn3JH | Facebook
Biogen looks to M&A to overcome competition to its MS franchise | Fierce Pharma
FAQ on FDA Approval of Aducanumab - CurePSP
pspawareness - Twitter Search / Twitter
Biogen Cancels Another Dementia Drug in Phase 2 Clinical Trial - Being Patient
Progressive Supranuclear Palsy Treatment Market Estimated to Reach A Valuation Of US$ 20.68 Million By 2027 – with AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., Merck & Co. Inc.,
Anti-Tau Drugs for PSP Move into Phase II - CurePSP
Gosuranemab: another Alzheimer's candidate to bite the dust
Biogen on Twitter: "Our #MultipleSclerosis (#MS) and progressive supranuclear palsy (#PSP) research will be highlighted in the poster sessions today at #AANAM https://t.co/4HA0yQOW8X" / Twitter
Research | Pipeline
Research - Tau Consortium
PSP — Coleen Heaver
Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 United States PROTOCOL NUMBER: 251PP301 / NCT03068468 Biogen Idec Research
Biogen | Contract Pharma
Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's | Fierce Biotech
Biogen on Twitter: "We'll be showcasing our work in neuroscience including the areas of multiple sclerosis (#MS), spinal muscular atrophy (#SMA), Alzheimer's Disease (#AD) and progressive supranuclear palsy (#PSP) with poster and
Biogen - Pioneers In Neuroscience
Biogen's Tau Antibody Fails In PSP, But Alzheimer's Studies Continue :: Scrip
Cover Layout Presentation name
